Arcellx (ACLX) Operating Expenses (2021 - 2025)
Arcellx (ACLX) recorded quarterly Operating Expenses of $65.3 million in Q4 2025, down 2.08% quarter-over-quarter from $66.7 million in Q3 2025, and down 4.5% on a YoY basis from $68.4 million in Q4 2024.
Arcellx (ACLX) Operating Expenses (2021 - 2025) Analysis & Trends
Arcellx's Operating Expenses history runs 5 years deep, the most recent figure standing at $65.3 million for Q4 2025.
- In Q4 2025, Operating Expenses fell 4.5% year-over-year to $65.3 million; the TTM figure through Dec 2025 stood at $275.4 million (up 12.16% YoY), while the FY2025 annual figure was $275.4 million, up 12.16% from the prior year.
- Operating Expenses was $65.3 million for Q4 2025 at Arcellx, down from $66.7 million in the prior quarter.
- In the past five years, Operating Expenses ranged from a high of $93.9 million in Q3 2022 to a low of $11.3 million in Q1 2021.
- Historically, Operating Expenses has averaged $48.9 million across 5 years, with a median of $51.7 million in 2023.
- The sharpest annual moves came in 2022 and 2023: Operating Expenses soared 448.66% in 2022, then plunged 36.28% in 2023.
- A 5-year view of Operating Expenses shows it stood at $20.7 million in 2021, then surged by 93.27% to $40.0 million in 2022, then grew by 20.36% to $48.1 million in 2023, then soared by 42.1% to $68.4 million in 2024, then decreased by 4.5% to $65.3 million in 2025.
- The last three Operating Expenses figures came in at $65.3 million (Q4 2025), $66.7 million (Q3 2025), and $66.3 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 4.33 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 32.68 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 2.97 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -138.30 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -3.82 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 15.76 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 574,669.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.85 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -67.40 Mn |
| 10 | Arcellx | 6.48 Bn | 6.48 Bn | - | 65.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 65.34 Mn |
| Sep 30, 2025 | 66.73 Mn |
| Jun 30, 2025 | 66.28 Mn |
| Mar 31, 2025 | 77.03 Mn |
| Dec 31, 2024 | 68.42 Mn |
| Sep 30, 2024 | 59.65 Mn |
| Jun 30, 2024 | 62.38 Mn |
| Mar 31, 2024 | 55.07 Mn |
| Dec 31, 2023 | 48.15 Mn |
| Sep 30, 2023 | 59.82 Mn |
| Jun 30, 2023 | 43.86 Mn |
| Mar 31, 2023 | 48.37 Mn |
| Dec 31, 2022 | 40.00 Mn |
| Sep 30, 2022 | 93.88 Mn |
| Jun 30, 2022 | 31.29 Mn |
| Mar 31, 2022 | 26.09 Mn |
| Dec 31, 2021 | 20.70 Mn |
| Sep 30, 2021 | 17.11 Mn |
| Jun 30, 2021 | 15.93 Mn |
| Mar 31, 2021 | 11.28 Mn |